The DOI matches its Crossref record.
B cell growth-promoting activity of recombinant human interleukin 4.
Abstract
Human interleukin 4 (IL-4), also known as B cell stimulatory factor 1, is a T cell-derived glycoprotein consisting of 129 amino acids for which a cDNA has been recently isolated. IL-4 displays little or no B cell growth factor (BCGF) activity in the standard anti-IgM costimulatory assay using suboptimal concentrations of soluble anti-IgM antibody whereas the low m.w. BCGF is very active. When insolubilized anti-IgM was used as the costimulating agent, both IL-4 and the low m.w. BCGF were found to promote B cell proliferation. Human IL-4 is able to induce the proliferation of B lymphocytes preactivated for either 1 day with insolubilized anti-IgM antibody or for 3 days with Staphylococcus aureus strain Cowan I. However, IL-4 is poorly mitogenic for B cells preactivated for 1 day with the Staphylococcus strain whereas the low m.w. BCGF strongly enhances the proliferation of these B cells. These two findings demonstrate that the preactivation signal necessary to induce human B cells to proliferate in response to IL-4 is critical. The increased tritiated thymidine ([3H]dThd) uptake in preactivated B cell cultures with IL-4 reflects cel proliferation because cell cycle analysis demonstrates that IL-4 induces activated B cells to enter the S and G2/M phases of the cell cycle and the addition of IL-4 to preactivated B cell cultures permits the recovery of three- to fourfold more B cells after 4 days of culture. IL-4 and the low m.w. BCGF act in concert to induce the proliferation of anti-IgM-preactivated B cells as demonstrated by [3H]dThd uptake and cell cycle analysis. In striking contrast to the demonstrated antagonistic effect of interferon-gamma on the IL-4-induced expression of the low affinity receptor for IgE (Fc epsilon RL/CD23), on B cells, it was found that interferon-gamma enhanced the IL-4-induced proliferation of anti-IgM-preactivated B cells. Finally, it was found that IL-4 had to be present continuously during the culture period to exert an optimal growth-promoting effect on B cell blasts. As a conclusion, IL-4 is able to induce the proliferation of an appropriately activated subpopulation of human B cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes
Rousset, F., Garcia, E., Defrance, T., Péronne, C., Vezzio, N., Hsu, D. H., Kastelein, R., Moore, K. W., & Banchereau, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1890 · Cited by 1,238
Self-citationPène, J., Rousset, F., Brière, F., Chrétien, I., Bonnefoy, J. Y., Spits, H., Yokota, T., Arai, N., Arai, K., & Banchereau, J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6880 · Cited by 924
Self-citationInterleukin-4: a prototypic immunoregulatory lymphokine
Paul, W. (1991) · Blood · doi:10.1182/blood.v77.9.1859.1859 · Cited by 880
Long-Term Human B Cell Lines Dependent on Interleukin-4 and antibody to CD40
Banchereau, J., de Paoli, P., Vallé, A., Garcia, E., & Rousset, F. (1991) · Science · doi:10.1126/science.1702555 · Cited by 533
BAFF selectively enhances the survival of plasmablasts generated from human memory B cells
Avery, D. T., Kalled, S. L., Ellyard, J. I., Ambrose, C., Bixler, S. A., Thien, M., Brink, R., Mackay, F., Hodgkin, P. D., & Tangye, S. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18025 · Cited by 509
te Velde, A., Huijbens, R., Heije, K., de Vries, J., & Figdor, C. (1990) · Blood · doi:10.1182/blood.v76.7.1392.1392 · Cited by 449
Self-citationDancescu, M., Rubio-Trujillo, M., Biron, G., Bron, D., Delespesse, G., & Sarfati, M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.5.1319 · Cited by 344
Interleukin-4 and lnterleukin-13: Their Similarities and Discrepancies
Chomarat, P., & Banchereau, J. (1998) · International Reviews of Immunology · doi:10.3109/08830189809084486 · Cited by 331
Rousset, F., Garcia, E., & Banchereau, J. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.705 · Cited by 329
Vannier, E., Miller, L. C., & Dinarello, C. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.4076 · Cited by 321
Saito, H., Hatake, K., Dvorak, A. M., Leiferman, K. M., Donnenberg, A. D., Arai, N., Ishizaka, K., & Ishizaka, T. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2288 · Cited by 316
Self-citationPène, J., Rousset, F., Brière, F., Chrétien, I., Wideman, J., Bonnefoy, J. Y., & Vries, J. E. D. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180615 · Cited by 261
Strategies targeting the IL-4/IL-13 axes in disease
May, R. D., & Fung, M. (2015) · Cytokine · doi:10.1016/j.cyto.2015.05.018 · Cited by 166
Interferon γ- and interleukin-4-secreting cells in multiple sclerosis
Lu, C.-Z., Jensen, M. A., & Arnason, B. G. W. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90241-p · Cited by 77
Metadata
- Authors
- Defrance, T., Vanbervliet, B., Aubry, J. P., Takebe, Y., Arai, N., Miyajima, A., Yokota, T., Lee, F., Arai, K. I., & de Vries, J. E.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1987-08
- Volume
- 139
- Issue
- 4
- Pages
- 1135-1141
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1959472468
- Cited by
- 205
- References
- 0
- FWCI
- 10.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.